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Abstract
Complete transcriptomic data at high resolution are available only for a few model organ-
isms with medical importance. The gene structures of non-model organisms are mostly
computationally predicted based on comparative genomics with other species. As a result,
more than half of the horse gene models are known only by projection. Experimental data
supporting these gene models are scarce. Moreover, most of the annotated equine genes
are single-transcript genes. Utilizing RNA sequencing (RNA-seq) the experimental valida-
tion of predicted transcriptomes has become accessible at reasonable costs. To improve
the horse genome annotation we performed RNA-seq on 561 samples of peripheral blood
mononuclear cells (PBMCs) derived from 85Warmblood horses. The mapped sequencing
reads were used to build a new transcriptome assembly. The new assembly revealed many
alternative isoforms associated to known genes or to those predicted by the Ensembl and/
or Gnomon pipelines. We also identified 7,531 transcripts not associated with any horse
gene annotated in public databases. Of these, 3,280 transcripts did not have a homologous
match to any sequence deposited in the NCBI EST database suggesting horse specificity.
The unknown transcripts were categorized as coding and noncoding based on predicted
coding potential scores. Among them 230 transcripts had high coding potential score, at
least 2 exons, and an open reading frame of at least 300 nt. We experimentally validated 9
new equine coding transcripts using RT-PCR and Sanger sequencing. Our results provide
valuable detailed information on many transcripts yet to be annotated in the horse genome.
PLOS ONE | DOI:10.1371/journal.pone.0122011 March 19, 2015 1 / 16
OPEN ACCESS
Citation: Pacholewska A, Drögemüller M,
Klukowska-Rötzler J, Lanz S, Hamza E, Dermitzakis
ET, et al. (2015) The Transcriptome of Equine
Peripheral Blood Mononuclear Cells. PLoS ONE
10(3): e0122011. doi:10.1371/journal.pone.0122011
Academic Editor: Cynthia Gibas, University of North
Carolina at Charlotte, UNITED STATES
Received: August 1, 2014
Accepted: February 6, 2015
Published: March 19, 2015
Copyright: © 2015 Pacholewska et al. This is an
open access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All 561 binary
alignment files (BAMs) are available from the
European Nucleotide Archive database (http://www.
ebi.ac.uk/ena/data/view/PRJEB7497).
Funding: The presented study was funded by Swiss
National Science Foundation (www.snf.ch): grant No.
310030-138295 and 310000-116803/1; and Swiss
Institute of Equine Medicine Research (ismequine.
ch). VG and EM have received the funding. The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
67
76
9 
| 
do
wn
lo
ad
ed
: 
13
.3
.2
01
7
Introduction
Morphology studies have shown that equine and human lungs bear a striking resemblance
[1,2]. In temperate climates 10% to 20% of stabled horses succumb to a condition called recur-
rent airway obstruction (RAO, also known as heaves) characterized by stable dust-induced in-
flammation, bronchospasm and airway remodeling. These characteristics are very similar to
human asthma. RAO is a naturally occurring disease, showing cumulative effects of multiple
episodes of dust-induced exacerbation in a context of complex gene and environment interac-
tions [3,4]. Another interesting characteristic is the highly sensitive response of horses to lipo-
polysaccharides (LPS), which is also similar to humans [5].
There is however limited information on the transcriptome profile of lung tissue and im-
mune cells in horses. This limitation comes from the fact that there is only a small number of
expressed sequence tags and cDNA data for horses deposited in public databases (37,756 en-
tries in NCBI dbEST, release 130101). Hence, the current gene models are derived based on a
combination of ab initiomethods, homology based studies, similarity and motif analysis pro-
grams. This is currently rapidly changing with several groups publishing digital gene analyses
from a variety of horse tissues, including muscle, leukocytes, cartilage, brain, reproductive tis-
sue, embryos, sperm, and blood [6–16]. These studies have catalogued several non-coding
genes in addition to protein coding gene isoforms, and structural annotations of existing genes.
The RNA-seq technology facilitates comprehensive whole transcriptome analyses without
previous knowledge of the transcriptome structure [17,18]. Short sequencing reads from
cDNA are either first mapped to the reference genome sequence or, in the absence of a refer-
ence genome, de novo assembled into transcript contigs [19–22]. This methodology also allows
to annotate non-coding genes and to find alternatively spliced isoforms for each gene locus
[10,21,23–25]. RNA-seq is particularly meaningful in studies of non-model organisms with
poor genome annotation. This technology enables the identification of new, and sometimes
even species-specific, transcripts. Using RNA-seq 13,086 unannotated transcripts (33% of all
transcripts identified in the study) were identified in bovine skin [24]. Park et al. identified
20,428 novel transcripts (60% of all transcripts identified in the study) expressed in equine
muscle and blood samples [6].
The equine gene set annotated by the Ensembl pipeline (build 72.2) contains 20,449 pro-
tein-coding genes and 4,400 pseudogenes. Despite the fact that the number of protein coding
genes is similar to human, there are only 1,635 equine protein coding genes (8%) with more
than one transcript annotated. In contrast, in human 18,516 (82%) from the 22,680 protein
coding genes have more than one transcript annotated. Therefore, any isoform-specific gene
expression analysis of the horse transcriptome, using the currently available set of annotated
transcripts, will be based on a highly incomplete annotation. Although it is computationally
more challenging, the expression analysis at the isoform level has been shown to be more accu-
rate in human gene expression studies [21,26–31].
To facilitate meaningful future global gene expression studies in horses we performed an
RNA-seq experiment with the goal of improving the structural annotation of the transcriptome
of peripheral blood mononuclear cells (PBMCs). PBMCs consist of cells involved in both in-
nate and adaptive immune response. Changes in the population of PBMCs after antigen stimu-
lation were reported in 1968 in humans and even earlier in animals [32]. The traffic of immune
cells in the blood during infection indicates the type of infection independent of its specific lo-
calization. Therefore, PBMCs are a common target of immunological studies.
Our analysis provides a very comprehensive snapshot of the equine PBMC transcriptome.
Moreover, this study highlights the value of RNA-seq in identifying novel genes and isoforms
that underlie the immune response to allergens.
Equine PBMCs Transcriptome
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Materials and Methods
Ethics statement
All animal experiments were performed according to the local regulations. The horses in this
study were examined with the consent of their owners. This study was fully approved by the
Ethical Committee of the Canton of Bern (BE33/07, BE58/10 and BE10/13).
Samples
We collected blood samples from 85Warmblood horses (stallions: n = 20, mares: n = 36, geld-
ings: n = 29). Among the horses, 40 were diagnosed with RAO, and 45 were RAO-non-affected.
The samples were collected as described [33]. All of the RAO-affected horses were in remission
phase at the time of sample collection. PBMCs were isolated by density gradient centrifugation
[34]. Approx. 8 x 106 PBMCs were then cultured in 4 ml medium for 24 hours with different
stimulating factors [33]. For this study, we used samples stimulated with lipopolysaccharides
(LPS of E. coli, Sigma–Aldrich) at a concentration of 250ng/ml (in the unrelated group of hors-
es 12 samples were stimulated with LPS at higher concentration: 5 or 10 μg/ml, and two sam-
ples were stimulated with LPS at lower concentration: 80 pg/ml); hay dust extract (HDE)
[33,35] at three concentrations: 12, 9 or 6 μg/ml; or recombinant cyathostomin antigen (RCA)
[36] at two concentrations: 4 or 1 μg/ml. As a reference, PBMCs were cultured under the same
conditions, but without stimulating factor (mock). In total, we studied 42 groups of samples
with 6 to 29 biological replicates per group. The exact number of replicates is given in S1 Table.
RNA isolation and sequencing
RNA was isolated from cultured cells as described in Lanz et al. [33]. We measured the quality
and quantity of the isolated RNA with an Agilent 2100 Bioanalyzer (Agilent Technologies) and
Qubit 2.0 Fluorometer (Life Technologies). Approximately 500 ng of high quality RNA (RNA
integrity number: RIN> 8) was used for non-directional paired-end RNA library preparation
(TruSeq Sample Preparation Kit v2 guide Part #15026495 Rev.D, Illumina).
Total mRNA libraries were randomly multiplexed in 12 samples per lane and sequenced on
the Illumina HiSeq2000 platform using 2 x 50 bp paired-end sequencing cycles. The Illumina
BCL output files with base calls and qualities were converted into FASTQ file format and
demultiplexed with the casava (v1.8.2) software.
Quality control of reads
The reads in FASTQ format were processed for quality checks using the FastQC tool (v0.10.1;
http://www.bioinformatics.babraham.ac.uk). The statistics on the number of reads per library,
base quality scores, read length, GC content, number of missing base calls, and number of
unique 15-mers was collected separately for the forward and reverse reads in each of the lanes.
Mapping
Good quality reads were then mapped to the most recent horse reference genome assembly,
EquCab2 [37], using the GEMmapper (v1.6.2) [38] guided by existing annotations from
Ensembl (release 72). For the GEMmapper (v1.6.2) we allowed for a maximum of two mis-
matches and a maximum intron length of 500 kbp. For all other parameters we kept the default
values. The guided procedure maps reads to existing gene regions. The procedure also allows
for mapping sequence reads to transcript regions not yet annotated in the reference genome.
Mapping quality control was performed using the RSeQC package [39]. The saturation status
of splicing junction detection, coverage uniformity over gene body, splice junction coverage of
Equine PBMCs Transcriptome
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known gene bodies, read distribution in the genome, and the origin (known/novel) of splice
sites were tested. The binary alignment files (BAMs) are available from the European Nucleo-
tide Archive (ENA) database (http://www.ebi.ac.uk/ena/data/view/PRJEB7497).
Transcriptome assembly
We assembled the reference based transcriptome for each sample using Cufflinks (v2.1.1)
[21,40]. All 561 assemblies were then merged into one transcriptome assembly, guided by ref-
erence gene structures, using Cuffmerge (v2.1.1) [40]. Reference transcripts not expressed in
any of the samples studied were discarded from the assembly.
Expression quantification
The merged file was used as a reference for the Cuffquant and Cuffnorm tools (Cufflinks
v2.2.0) for the transcript abundance estimation [40]. We estimated the median of fragment per
kilobase per million fragments mapped (FPKM) for each transcript. Transcripts with expres-
sion values less than 0.01 FPKM per sample were considered as lowly expressed transcripts and
excluded from further analysis.
Identification of unknown transcripts
The merged assembly was compared with the reference gene models predicted by either the
Ensembl or the NCBI pipelines on the EquCab2 genome assembly, available in public data-
bases. Subsequently, we eliminated all the transcripts that corresponded to known/predicted
models. The final reduced data set contained only transcripts with class code “u”, according to
Cuffcompare, and we refer to them from here on as unknown transcripts.
Classification of unknown transcripts
We obtained FASTA formatted sequences from the horse reference genome for each unknown
transcript using the gffread function of Cufflinks (v2.1.1). We then performed sequence ho-
mology searches against the expressed sequence tags database (dbEST, NCBI, release 130101)
[41] using the BLASTN algorithm (v2.2.26+, e-value threshold = 1e-5) [42].
All unknown transcripts were then evaluated for coding potential using the Coding Poten-
tial Calculator (CPC) [43]. The CPC tool uses support vector machines to calculate the coding
potential of a transcript. It takes e.g. open reading frame (ORF) length, sequence conservation,
and alignment information into consideration for the prediction. It estimates the coding poten-
tial scores: negative for non-coding, positive for coding transcripts. According to the program’s
documentation, transcripts with a score between zero and one have weak coding potential. All
transcripts with positive coding score and without match in the EST database were considered
as potentially new horse-specific protein coding transcripts.
Validation of potentially coding transcripts
Potentially coding transcripts with at least two exons, an ORF 300 bp, and mean expression
across samples 1 FPKM were selected for experimental validation by reverse transcription
polymerase chain reaction (RT-PCR). RNA samples for experimental confirmation were re-
verse transcribed into cDNA using SuperScript II reverse transcriptase (Invitrogen) and oligo
(dT) primers. The cDNA was then used for PCR amplification with specific primers designed
with Primer3Web (v4.0.0.0) [44,45] and AmpliTaq Gold 360 Mastermix (Applied Biosystems).
The PCR steps were as follows: initial denaturation (95°C for 10 min); 36 cycles of denaturation
(95°C for 30 s), annealing (58°C for 30 s), and extension (72°C for 40 s); and final extension
Equine PBMCs Transcriptome
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(72°C for 7 min). RT-PCR products were directly sequenced on an ABI 3730 capillary sequenc-
er (Applied Biosystems) after treatment with exonuclease I (New England Biolabs) and rAPid
Alkaline Phosphatase (Roche). We analyzed the Sanger sequence data with Sequencher 5.1
(GeneCodes).
Results
Sequencing and mapping
In this study, we sequenced 561 RNA libraries derived from in vitro stimulated equine PBMCs.
We obtained between 8,590,084 and 141,367,074 paired-end reads per library (17 million
paired-end reads per library on average, S1 Fig.). In total, our dataset consisted of 19.33 billion
(109) reads of length 49 bp. The quality of the reads was high–the mean base quality score in
the Phred scale [46,47] was 35.68, indicating that the base call accuracy was above 99.97%. The
reads were characterized by high variation in the sequence content, and there were no indica-
tions of high level of duplication or GC-bias (on average almost 107 unique 15-mers and
49.35% GC content per sample).
The reads were mapped to the EquCab2 reference genome with the GEMmapper. The effi-
ciency of the mapping was high and reached 93% with 18.16 x 109 mapped reads and 17.09 x
109 uniquely mapped reads. Less than half of the reads (n = 7.8 x 109; 40%) covered known
exons of 22,229 genes from a total of 26,991 genes annotated in Ensembl (Ensembl, release 72)
(S1 Fig.). Of the 22,229 genes explained by at least one read in our dataset, 20,617 (93%) are
currently annotated as single-transcript genes by Ensembl. The mapped reads were used for
generating a new transcriptome for PBMCs. The principal steps of the analysis are shown in
Fig. 1.
Transcriptome assembly
On average, one individual RNA-seq assembly consisted of 39,921 transcripts belonging to
34,132 genes. The individual RNA-seq assemblies contained 35% single-exon transcripts on av-
erage. We then merged the 561 individual transcript assemblies into one merged assembly.
Due to the low proportion of reads spanning the Ensembl gene structures, the merge was guid-
ed by annotations from Ensembl (Ensembl, release 72) and NCBI Gnomon (NCBI, release
101).
After merging the 561 assemblies and removing non-expressed reference sequences, the
merged assembly included 316,457 transcripts expressed from 42,615 gene loci. The number of
single-transcript genes was 17,136 (40%). We discovered 8,483 new gene loci from the merged
assembly. Two thirds of the single-transcript genes (n = 11,802; 69%) were associated with
equine genes already annotated in Ensembl or NCBI databases.
As expected, we identified the highest number of exons on the biggest chromosome, chro-
mosome 1 (33,197 exons). However, the number of exons did not always correlate with chro-
mosome length. On chromosomes 9 and 10, which have very similar lengths, the numbers of
exons differed by more than twofold (8,847 and 20,151 exons). The distribution of the number
of exons and number of transcripts per chromosome in the new transcriptome assembly is
shown in Fig. 2. The annotation GTF file for the new assembly is available as S1 File.
Expression quantification
Most of the read pairs mapped to known/predicted gene models (Ensembl and NCBI). These
read pairs were either assembled with complete match to the reference transcripts or predicted
to represent new isoforms of the reference genes. Only 1% of the fragments were assembled
Equine PBMCs Transcriptome
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into new transcripts (5.95 x 107 fragments; 7,541 transcripts). The number of transcripts
mapped to Ensembl/NCBI annotated horse genes is shown in Fig. 3.
Transcript expression across samples varied from 0 to 1.62 x 106 FPKM. The calculated me-
dian expression per transcript across samples ranged from 0 to 74,180 FPKM. The protein cod-
ing reference transcript with the highest expression (max. 26,557 FPKM) was interleukin 8
(IL8) that plays a key role in the inflammatory processes attracting leukocytes (mostly neutro-
phils) from the blood to the sites of inflammation [48]. Among transcripts with the highest ex-
pression were also other mediators of inflammation: CXCL2 (max. 16,806 FPKM), CCL2 (max.
13,357 FPKM), and CCL8 (max. 11,441 FPKM). Additional information, such as e.g. transcript
length and expression values for each transcript, is given in the supplementary S2 File.
The statistics of the new transcriptome assembly with the number of known and unknown
transcripts, after filtering out lowly expressed transcripts (with expression values less than 0.01
FPKM per sample), is shown in Table 1.
Analysis of unknown transcripts
The 7,531 unknown transcripts contained between one and seven exons (Fig. 4) and spanned
from 49 to 44,080 bp. The majority of these transcripts (n = 5,281; 70%) were single-exon
Fig 1. Workflow of the analysis. The principal steps of the analysis and the format of the output files are given.
doi:10.1371/journal.pone.0122011.g001
Equine PBMCs Transcriptome
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transcripts (Table 1) of length range 49–41,526 bp (median = 1,448 bp). The expression of the
unknown transcripts across samples ranged from 0 to 1.87 x 106 FPKM (median = 1.23 FPKM;
mean = 389.60 FPKM).
Of the 7,531 unknown transcripts 4,251 (57%) had a hit after blasting against the NCBI EST
database, release 130101 (bit score range: 60.2–1,855; median = 268). These transcripts were
not considered as horse-specific transcripts as they had a homologous transcript annotated for
other species.
Classification of unknown transcripts
All 7,531 unknown transcripts were subjected to CPC prediction of the coding potential to
classify them into protein-coding or non-coding RNA. The majority of the unknown tran-
scripts were classified as non-coding, while 1,104 were predicted to have putative coding poten-
tial when both strands were tested (S3 File). Roughly half of these (543 transcripts, 49%) had a
coding potential with a score above one.
The median length of proteins, encoded by all unknown transcripts classified as coding, was
126 amino acids (aa) with a range of 16–1,453 aa (S2 Fig.).
From the potentially coding transcripts 157 did not match any EST deposited in NCBI EST
database and were considered to represent new horse-specific transcripts. An example of the
potentially new horse-specific coding transcript from chromosome 9 is shown in Fig. 5.
Validation of potentially coding transcripts
For the validation of the unknown coding transcripts we focused on transcripts with CPC
score 1, at least one spliced intron, an ORF 300 bp, and mean FPKM values 1.
Fig 2. Distribution of exons and transcripts identified in the new transcriptome assembly. The number of exons and transcripts is shown on the y-axis
on the left; the length of chromosomes in base pairs is shown on the y-axis on the right.
doi:10.1371/journal.pone.0122011.g002
Equine PBMCs Transcriptome
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We selected 13 of these transcripts and designed primer pairs for RT-PCR amplification (S2
Table). Among these 13 transcripts, one was potentially horse-specific (ECAUB_00002829).
We selected an RNA sample with predicted high expression, and performed RT-PCR. Nine out
of the 13 expected amplification products, including ECAUB_00002829, were detected by elec-
trophoresis (Fig. 6). All nine RT-PCR products were Sanger sequenced and showed a perfect
match to the predicted transcripts. The sequences of the verified new horse transcripts are
given in S4 File.
Discussion
The currently available horse genome annotation is still incomplete and contains mostly one
single transcript per gene. We used our large RNA-seq dataset to improve the annotation of
the horse genome and to characterize the transcriptome of equine PBMCs. Despite high map-
ping efficiency, less than half of the sequencing reads in our dataset spanned gene regions pre-
dicted by the Ensembl pipeline (S1 Fig.).
Fig 3. Number of transcripts. The number of transcripts mapped to known/predicted gene models
annotated in the Ensembl/NCBI databases and assembled into unknown transcripts.
doi:10.1371/journal.pone.0122011.g003
Equine PBMCs Transcriptome
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While the Ensembl pipeline predicts gene models based on known proteins, experimental
cDNA and EST sequences [48], the NCBI Gnomon pipeline also makes ab inito predictions,
which may be fully or partially supported by hypothetical sequence records (with XM_ acces-
sions numbers) from other model organisms, and therefore expands the pool of predicted tran-
script sequences [49]. We used a merged transcriptome from the Ensembl and NCBI data for
our analyses to have the most comprehensive reference transcriptome.
Our equine PBMC transcriptome was expressed from 42,602 predicted genes compared to
63,877 genes annotated in the human genome (Ensembl release 75). However, when
Table 1. Statistics on the horse PBMCs transcriptome assembly.
Class a # transcripts # genes # single-exon transcripts
Unknownb 7,531 6,006 5,281
Complete match to annotatedc 59,103 26,493 7,705
Novel isoformsd 129,309 11,717 0
Othere 89,595 12,321 418
TOTAL 285,538 42,602 13,404
aThe numbers of transcripts identiﬁed in the assembly are given after ﬁltering transcripts with expression values less than 0.01 FPKM per sample. The
classes are deﬁned according ton the Cufﬂinks manual [21]:
bUnknown, intergenic transcripts
cTranscripts with complete match of intron chain to reference transcript
dPotentially novel isoform with at least one splice junction shared with a reference transcript
eTranscripts with an intron overlapping a reference intron on the opposite strand (n = 74,073); transcripts with generic exonic overlap with a reference
transcript (n = 12,700); transcripts with an exonic overlap with reference on the opposite strand (n = 2,780); transcripts falling entirely within a reference
intron (n = 39); possible polymerase run-on fragment (n = 2); possible repeat sequence (n = 1).
doi:10.1371/journal.pone.0122011.t001
Fig 4. Distribution of the number of exons in the putative new equine transcripts.
doi:10.1371/journal.pone.0122011.g004
Equine PBMCs Transcriptome
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comparing these numbers one also needs to consider that we analyzed only PBMCs whereas
the human transcriptome annotation is based on a comprehensive collection of tissues and
cell types.
The transcript-to-gene ratio in our dataset was 6.70. In contrast, the Ensembl horse annota-
tion contains only slightly more than one transcript per gene (protein coding–1.11; all–1.08;
Ensembl release 72). The gene structures reported here were predicted from short-read data
and should be taken with some caution. Many of our initially predicted transcripts (n = 30,919;
10%) were expressed at very low level (max. expression across samples< 0.01 FPKM) and fil-
tered out before the secondary analysis steps. There were 2,323 (0.81%) non-overlapping tran-
scripts that belonged to the same gene locus. Only 95 of them represented unknown
Fig 5. Example of a new putative horse-specific coding transcript. The new transcript is indicated in the UCSC Genome Browser view.
doi:10.1371/journal.pone.0122011.g005
Fig 6. Experimental verification of the expression of predicted new equine transcripts. An agarose gel with transcripts amplified by 36 cycles of
RT-PCR is shown.
doi:10.1371/journal.pone.0122011.g006
Equine PBMCs Transcriptome
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transcripts. It is possible that those non-overlapping transcripts do not well represent the true
transcript structures. Moreover, 5,824 transcripts (2.04%) had the same splice sites and differed
only in the length of the first and/or last exon, but were nonetheless described as a new isoform
by Cufflinks. We considered this as a discrepancy and these transcripts were marked as dupli-
cates. Sequencing errors, which are common at the ends of the reads, or genomic sequence var-
iations could also be a potential source of such instances. Small changes in the DNA sequence
could either mask the true or create novel splice sites with resulting incorrect exon annotations.
However, two isoforms with different exon lengths could also both be real. Therefore, we kept
all the transcripts identified in our assembly.
We found 7,215 (2.53%) transcripts containing at least one exon with length shorter than 10
nt. Most of these transcripts were associated with Ensembl/NCBI equine transcripts, and only
eight represented unknown transcripts. There are only 1,586 (0.75%) exons shorter than 10 nt
in the human RefSeq database (NCBI, status from 19th June 2014). These exons belong to
2,241 mRNA sequences from which 1,286 had reviewed status (available sequence data in the
literature), 879 validated (after initial review), 65 provisional (not yet subjected for review), 6
predicted, and 5 inferred (predicted and not yet supported by experimental evidence) [50].
Therefore, we suggest treating such transcripts with caution.
Despite the fact that only 4,733 (0.93%) exons did not have a defined strand of origin, we
identified 138,559 (27.13%) exons that were reported by Cufflinks on both strands. We will
refer to both of these types of exons as ‘unsure’. One explanation for the exons not having
strand information is the missing XS tag in the initial BAM file, produced by the GEMmapper.
The XS tag gives information on the strand origin of the read and has two values: “+” and “-“.
In spliced reads the presence of the XS tag is required by Cufflinks for the correct transcript as-
sembly. In our data, there were 2,838,996 spliced reads (0.01% of the total number of reads)
without XS tag. Most of those reads (2,730,237; 96.17%) spanned the unsure exons. We further
investigated the reads without XS tags. The size of the skipped region from the reference se-
quence (“N” in CIGAR string of the SAM format [51]) ranged from to 4 to 499,583 nt and
1,604 reads had skipped regions shorter than 50 nt indicating probably incorrect intron place-
ments. The edit distance from the reference in the reads without XS tag ranged from 1 to 35
bases. In most of those reads (2,449,712; 86.29%) the identified splice site was flanked, at least
on one side, by a small deletion, insertion, or soft clipped sequence. Therefore, assignment of
the strand of the read origin by the GEMmapper was not possible. From the remaining reads
without InDel or clipped sequence, 380,600 reads (13.41%) had more than one skipped region
in the CIGAR string. For such short reads (49 bp) more than one skipped region indicated
rather incorrect mapping, as it is very unlikely for a transcript to have two exons with the sum
of their length less than 49 bp.
Although our assembly is based on short-read data, which may lead to various sorts of arti-
facts, we strongly believe that our dataset improves the knowledge on the horse transcriptome.
We report here many new isoforms of existing genes and new, so far unannotated transcripts,
mapping outside of the predicted loci of the horse genome assembly. These unknown tran-
scripts mapping outside previously annotated genes are of major interest to us as they might
play a role in determining RAO response and genetic predisposition, and hence were subjected
for further analysis and classification. Of the 7,531 unknown transcripts we predicted that 543
have a strong coding potential (above one). Of those, 61 transcripts, expressed from 56 gene
loci, did not have a hit after blasting against dbEST (NCBI, release 130101) and were consid-
ered as new horse-specific transcripts. The CPC software had a reasonable performance when
the horse genome annotation from Ensembl (version 72) was tested. From the 6,218 transcripts
known to be expressed in horses (gene type “protein-coding”, transcript status “known”) CPC
identified 5,328 (85.69%) as transcripts with coding potential. The CPC software uses both
Equine PBMCs Transcriptome
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information on open reading frames, and hits against the non-redundant protein database
UniProt Reference Clusters (UniRef90) [52]. Therefore the new horse-specific transcripts iden-
tified in this study will have lower coding scores since they have no homologs in the protein da-
tabase. As the coding potential prediction is purely computational, it should be regarded
with caution.
From the 13 transcripts used for validation of the unknown transcripts, we successfully am-
plified 9 transcripts (Fig. 6). Because all transcripts were amplified using the same PCR condi-
tions, it is possible that optimization of the PCR reaction could lead to better amplification of
the remaining 4 transcripts. Although many unknown horse-specific transcripts appeared to
be well defined, the gene structures from this study should be further investigated and
experimentally confirmed.
Conclusions
Our study provides a significant improvement of the horse transcriptome derived from a large
RNA-seq dataset. With 561 samples derived from in vitro cultured PBMCs of 85 Warmblood
horses we were able to identify roughly 137 thousand transcripts that have not been previously
annotated. Moreover, we assembled more than seven thousand putative new horse transcripts
from which 61 were potentially new horse-specific transcripts with a strong coding potential.
We experimentally confirmed the expression of 9 out of 13 unknown coding transcripts by
RT-PCR.
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S1 Fig. The efficiency of mapping with GEMmapper. The boxplots of: total reads–the num-
ber of sequencing reads per library;mapped reads–the number of reads, mapped to the refer-
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protein length in amino acids. If a transcript had a coding potential on both strands only the
strand with the highest score was used for this analysis.
(EPS)
S1 Table. Number of replicates per subset of samples studied.
(DOCX)
S2 Table. The primer sequences for PCR and Sanger sequencing validation of the new tran-
scripts.
(DOCX)
S1 File. The new horse transcriptome annotation file. Transcripts expressed in in vitro stim-
ulated peripheral blood mononuclear cells of RAO-affected and RAO-non-affected thorough-
bred horses. Lowly expressed transcripts with max. FPKM per sample< 0.01 were filtered out.
(ZIP)
S2 File. Newly assembled transcripts description. For each transcript present in the S1 File
the following attributes are given: transcript id, gene id, minimum exon length, maximum
exon length, number of exons, strand, chromosome name, start position, end position, length,
was the transcript a duplicate, minimum FPKM value per sample, median FPKM value per
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sample, median FPKM value per sample, class code, nearest reference id, gene short name,
reference source.
(ZIP)
S3 File. The results of coding potential analysis with Coding Potential Calculator tool. As
input transcripts with class code “u” (potentially new transcripts) from S1 File were taken.
Both strands (forward and reverse) were tested for coding potential. The file contains header as
the first comment line.
(XLSX)
S4 File. Sequences of the amplified RT-PCR products in MULTIFASTA format. The con-
sensus sequences of 9 tested unknown horse-specific transcripts were obtained using the
Sequencher 5.1 (GeneCodes) software.
(TXT)
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